180 Life Sciences Corp (ATNF) — Financial Flexibility Index
180 Life Sciences Corp (ATNF) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-16.30 Million (operating CF $-16.30 Million minus capex $3.00) represents 0% of total liabilities ($564.18 Million). Check ATNF capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
180 Life Sciences Corp Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for 180 Life Sciences Corp across 8 annual periods. See 180 Life Sciences Corp (ATNF) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for 180 Life Sciences Corp (2017–2024)
Year-by-year free cash flow to debt coverage for 180 Life Sciences Corp. For the full company profile including market capitalisation, see market value of 180 Life Sciences Corp.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.42x | $-1.48 Million | $-1.48 Million | $3.51 Million | ▲ +79.2% |
| 2023 | -2.03x | $-10.92 Million | $-10.92 Million | $5.39 Million | ▼ -38.9% |
| 2022 | -1.46x | $-12.13 Million | $-12.13 Million | $8.31 Million | ▼ -782.0% |
| 2021 | -0.17x | $-3.87 Million | $-3.87 Million | $23.39 Million | ▼ -7.9% |
| 2020 | -0.15x | $-3.87 Million | $-3.87 Million | $25.25 Million | ▲ +35.7% |
| 2019 | -0.24x | $-3.17 Million | $-3.32 Million | $13.31 Million | ▼ -187.2% |
| 2018 | -0.08x | $-758.40K | $-789.23K | $9.14 Million | ▲ +29.3% |
| 2017 | -0.12x | $-497.36K | $-497.36K | $4.23 Million | — |